| Tigecycline EP Impurity B (USP Impurity D) | 149934-19-0 | C23H28N4O7 |
| Tigecycline EP Impurity B HCl | 149934-21-4 | C23H29ClN4O7 |
| Tigecycline for system suitability | 220620-09-7 | C29H39N5O8 |
| Tigecycline Hydrochloride | 197654-04-9 | C29H40ClN5O8 |
| Tigecycline Impurity 24 | 866602-58-6 | C29H39N5O9 |
| Tigecycline Impurity 26 | 6939-24-8 | C6H12N2O3 |
| Tigecycline Impurity 27 | Not available | C28H36N6O9 |
| Tigecycline Impurity 28 | Not available | C28H36N6O9 |
| Tigecycline Impurity 39 | 1207283-85-9 | C27H31FN4O8 |
| Tigecycline impurity B | Not available | C23H28N4O7 |
| Tigecycline impurity B | Not available | C23H28N4O7 |
| Tigecycline Impurity G (9-Nitro Minocycline) | 149934-16-7 | C23H26N4O9 |
| Tigecycline Impurity H | 1268494-40-1 | C27H32N4O9 |
| Tigecycline Intermediate | 6939-23-7 | C6H14ClNO2 |
| Tigecycline Mesylate | 1135871-27-0 | C30H43N5O11S |
| Tigecycline Pentacyclic Analog, Technical Grade | 1268494-40-1 | C27H32N4O9 |
| Tigecycline Related Compound B | 149934-21-4 | C23H29ClN4O7 |
| Tigecycline Sidechain | 915725-52-9 | C6H13Cl2NO |
| Tigecycline USP Impurity C | 1633815-62-9 | C29H37N5O8 |
| Tigecycline USP Impurity F | 1268494-46-7 | C26H32N4O8 |
| Tilidine | 51931-66-9 | C17H23NO2 |
| Tilidine for system suitability | 51931-66-9 | C17H23NO2 |
| Tilidine HCl | 27107-79-5 | C17H24ClNO2 |
| Tilidine Hydrochloride Hemihydrate Imp. A (EP): Ethyl (1RS,2RS)-2- (Dimethylamino)-1-phenylcyclohex-3- enecarboxylate (cis-Tilidine) | 20380-56-7 | C17H23NO2 |
| Tilidine Hydrochloride Hemihydrate Imp. D (EP) as Hydrochloride: Ethyl (2RS)-3- Dimethylamino-2-phenylpropanoate Hydrochloride | 24811-92-5 | C13H20ClNO2 |
| Tilolison | 362665-56-3 | C17H26ClNO |
| Timidina | 50-89-5 | C10H14N2O5 |
| Timina | 65-71-4 | C5H6N2O2 |
| Timolol EP Impurity A | 26839-76-9 | C13H24N4O3S |
| Timolol EP Impurity A Maleate Salt | 26839-77-0 | C17H28N4O7S |
| Timolol EP Impurity B | 59697-06-2 | C13H24N4O3S |
| Timolol EP Impurity D | 30165-97-0 | C6H9N3O2S |
| Timolol EP Impurity E | 1026075-53-5 | C17H26N4O6S |
| Timolol EP Impurity F | 30165-96-9 | C6H8ClN3OS |
| Timolol EP Impurity G | 75202-36-7 | C6H9N3O3S |
| Timolol EP Impurity H | 158636-97-6 | C13H24N4O3S |
| Timolol EP Impurity I | 2469037-77-0 | C11H20N4O3S |
| Timolol EP Impurity J | Not available | C16H32N4O4S |
| Timolol for system suitability | 26921-17-5 | C17H28N4O7S |
| Timolol Fumarate | 1820576-27-9 | C17H28N4O7S |
| Timolol Impurity 1 | 75014-25-4 | C13H24N4O5S |
| Timolol Impurity 2 | 75014-26-5 | C11H22N4O3S |
| Timolol Impurity 3 | 1227468-61-2 | C13H24N4O4S |
| Timolol Impurity 14 | 214691-24-4 | C6H9N3OS |
| Timolol Impurity 15 | 69500-53-4 | C9H13N3O3S |
| Timolol impurity F | 30165-96-9 | C6H8ClN3OS |
| Timolol Maleate | 57073-55-9 | C17H28N4O7S |
| Timolol Maleate Imp. D (EP): 4-(Morpholin-4-yl)-1,2,5-thiadiazol- 3-ol | 30165-97-0 | C6H9N3O2S |
| Timolol Maleate Imp. F (EP): 4-(4-Chloro-1,2,5-thiadiazol-3- yl)morpholine | 30165-96-9 | C6H8ClN3OS |
| Timolol Maleate Imp. G (EP): 4-(Morpholin-4-yl)-1,2,5-thiadiazol-3(2H)-one 1- Oxide (3-Hydroxy-4-morpholino-1,2,5-thiadiazole 1-Oxide) | 75202-36-7 | C6H9N3O3S |
| Timolol Related Compound B | 59697-06-2 | C13H24N4O3S |
| Timolol Related Compound D | 30165-97-0 | C6H9N3O2S |
| Timolol Related Compound E | 1026075-53-5 | C17H26N4O6S |
| Timolol Related Compound F | 30165-96-9 | C6H8ClN3OS |
| Timosaponin I | 163047-21-0 | C39H66O14 |
| Tini impurity 1 (Axitinib Impurity 17) | 398487-31-5 | C11H7ClN2O |
| Tinic acid (Axitinib Impurity 18) | 40180-04-9 | C13H8Cl2O4S |
| Tinidazole Denitrification Impurity 1 | 79318-98-2 | C8H14N2O2S |
| Tinidazole EP Impurity A | 88054-22-2 | C4H5N3O2 |
| Tinidazole EP Impurity B | 25459-12-5 | C8H13N3O4S |
| Tinidazole Imp. A (EP): 2-Methyl-5-nitro-1H-imidazole (2-Methyl-4-nitroimidazole) | 696-23-1 | C4H5N3O2 |
| Tinidazole Imp. B (EP): 1-[2-(Ethylsulfonyl)ethyl]-2-methyl-4-nitro-1H- | 25459-12-5 | C8H13N3O4S |
| Tinidazole Impurity 4 | 159790-77-9 | C7H11N3O4S |
| Tinidazole Impurity 11 | 140165-54-4 | C8H13N3O4S |
| Tinidazole Impurity 12 | 159790-76-8 | C7H11N3O4S |
| Tinidazole impurity A | 696-23-1 | C4H5N3O2 |
| Tinidazole impurity A | 696-23-1 | C4H5N3O2 |
| Tinidazole impurity B | 25459-12-5 | C8H13N3O4S |
| Tinidazole Related Compound A | 696-23-1 | C4H5N3O2 |
| Tinidazole Related Compound B | 25459-12-5 | C8H13N3O4S |
| Tinostamustine (EDO-S101) | 1236199-60-2 | C19H28Cl2N4O2 |
| Tioconazole for system suitability | 65899-73-2 | C16H13Cl3N2OS |
| Tioconazole Imp. A (EP) as Hydrochloride: 1-[(2RS)-2-(2,4-Dichlorophenyl)- 2-[(thiophen-3-yl)methoxy]ethyl]-1H-imidazole Hydrochloride | 61709-33-9 | C16H15Cl3N2OS |
| Tioconazole Related Compound A | 61709-33-9 | C16H15Cl3N2OS |
| Tioconazole Related Compound B | 61675-62-5 | C16H13Cl5N2OS |
| Tiopronin impurity 1 | 177219-40-8 | C11H20N2O2 |
| Tiopronin impurity 2 | 5438-83-5 | C8H14N2O5 |
| Tiotropium Bromide Monohydrate Imp. B (EP): (1R,2R,4S,5S,7s)-9-Methyl-3-oxa-9- azatricyclo[3.3.1.02,4]nonan-7-yl 2-Hydroxy-2,2- dithiophen-2-ylacetate | 136310-64-0 | C18H19NO4S2 |
| Tiotropium Bromide Monohydrate Imp. E (EP): Methyl 2-Hydroxy-2,2-dithiophen-2-ylacetate | 26447-85-8 | C11H10O3S2 |
| Tiotropium Bromide Monohydrate Imp. F (EP): Dithiophen-2-ylmethanone | 704-38-1 | C9H6OS2 |
| Tiotropium impurity 1 | 588-63-6 | C9H11BrO |
| Tiotropium Related Compound C | 136310-95-7 | C19H22BrNO3S2 |
| Tirenzepine dihydrochloride | 147416-96-4 | C19H24Cl2N4O2S |
| Tirofiban | 144494-65-5 | C22H36N2O5S |
| Tirofiban Hydrochloride | 150915-40-5 | C22H39ClN2O6S |
| Tirofiban Impurity 19 | 158808-75-4 | C18H28N2O3 |
| Tirofiban Impurity 25 | 14674-02-3 | C9H21NO2S |
| Tirofiban Impurity A | 149490-60-8 | C13H19NO5S |
| Tirofiban Impurity B | 149463-65-0 | C9H13Cl2N |
| Titropium bromide EP impurity A | 4746-63-8 | C10H8O3S2 |
| Titropium bromide EP impurity A (sodium salt) | 877467-46-4 | C10H7NaO3S2 |
| Titropium bromide EP impurity C Bromine | 136310-95-7 | C19H22BrNO3S2 |
| Titropium bromide EP impurity F | 704-38-1 | C9H6OS2 |
| Titropium bromide EP impurity G Bromine | 1508-46-9 | C9H16BrNO2 |
| Titropium bromide EP impurity H Bromine | 845870-40-8 | C9H16BrNO2 |
| Tizanidine | 51322-75-9 | C9H8ClN5S |
| Tizanidine EP Impurity A | 51322-69-1 | C9H9N5S |
| Tizanidine EP Impurity B | 51323-05-8 | C7H5ClN4S2 |
| Tizanidine EP Impurity C | 1147548-83-1 | C16H14Cl2N10S2 |
| Tizanidine EP Impurity D | 560120-68-5 | C8H7ClN4S2 |
| Tizanidine EP Impurity D Hydriodide Salt | 51323-03-6 | C8H8ClIN4S2 |
| Tizanidine EP Impurity E | 30536-19-7 | C6H4ClN3S |
| Tizanidine EP Impurity F | 1147548-85-3 | C16H11Cl2N9S2 |
| Tizanidine EP Impurity G | 51322-80-6 | C7H3ClN4S |
| Tizanidine Hydrochloride Imp. E (Pharmeuropa): 5-Chloro-2,1,3-benzothiadiazol-4-amine (4-Amino-5-chloro-2,1,3-benzothiadiazole) | 30536-19-7 | C6H4ClN3S |
| Tizanidine Hydrochloride Imp. I (Pharmeuropa) as Hydrate: 4-Methylbenzenesulfonic Acid Hydrate (p-Toluenesulfonic Acid Hydrate) | 6192-52-5 | C7H10O4S |
| Tizanidine Impurity 1 | 22308-12-9 | C19H24O6S2 |
| Tizanidine impurity B | 64461-82-1 | C9H9Cl2N5S |
| Tizanidine impurity B | 64461-82-1 | C9H9Cl2N5S |
| Tizanidine impurity B | 51323-05-8 | C7H5ClN4S2 |
| Tizanidine Related Compound A | 30536-19-7 | C6H4ClN3S |
| Tizanidine Related Compound B | 173532-15-5 | C11H10ClN5OS |
| Tizanidine Related Compound C | 5391-52-6 | C5H8N2OS |
| Tizanidine USP Related Compound B | 173532-15-5 | C11H10ClN5OS |
| Tizanidine USP Related Compound C | 5391-52-6 | C5H8N2OS |
| Tizoxanide | 173903-47-4 | C10H7N3O4S |
| Tobramycin EP Impurity A | 4696-76-8 | C18H37N5O10 |
| Tobramycin EP Impurity B | 34051-04-2 | C12H26N4O5 |
| Tobramycin for identification | 32986-56-4 | C18H37N5O9 |
| Tobramycin Impurity 8 | 64332-33-8 | C19H38N6O10 |
| Tobramycin Impurity 12 | 15446-43-2 | C12H30Cl4N4O6 |
| Tobramycin Related Compound A | 20744-51-8 | C12H25N3O7 |
| Tocopherol acetate | 7695-91-2 | C31H52O3 |
| Tocopherol Dimer Impurity 1 | 1604-73-5 | C58H96O4 |
| Tocopherol Dimer Impurity 2 | 2896-55-1 | C58H98O4 |
| Tocopherol EP Impurity A (Diastereomers) | 185672-33-7 | C29H50O2 |
| Tocopherol EP Impurity C | 90510-39-7 | C30H52O2 |
| Tocopherol EP Impurity D | Not available | C40H76 |
| Tocopherol impurities9 | 72657-56-8 | C29H50O3 |
| Tocopherol impurities 17 | 58864-81-6 | C29H44O2 |
| Tocopherol impurities 18 | 14101-61-2 | C28H42O2 |
| Tocopherol impurities 19 | 7083-09-2 | C19H28O4 |
| Tocopherol impurities 20 | 4072-32-6 | C16H22O4 |
| Tocopherol impurities 21 | 178167-75-4 | C15H20O4 |
| Tocopherol Impurity 1 | 3808-26-2 | C29H48O2 |
| Tocopherol Impurity 2 (Deshydroxy Tocopherol Quinone) | 75917-94-1 | C29H50O2 |
| Tocopherol Impurity 8 | 14745-36-9 | C29H52O3 |
| Tocoquinone | 7559-04-8 | C29H50O3 |
| Tofacitinib | 477600-75-2 | C16H20N6O |
| Tofacitinib Impurity 5 | 1062580-52-2 | C14H24Cl2N2 |
| Tofacitinib Impurity 7 | 90213-66-4 | C6H3Cl2N3 |
| Tofacitinib Impurity 8 | 3430-27-1 | C6H8N2 |
| Tofacitinib Impurity 36 | 2504210-41-5 | C29H38N10O2 |
| Tofacitinib Impurity F | 477600-74-1 | C13H19N5 |
| Tofacitinib Impurity N (Citrate) | 1809002-40-1 | C22H30N6O8 |
| Tofatinib Impurity 1 | 479633-63-1 | C13H10ClN3O2S |
| Tofatinib Impurity 2 | 477600-73-0 | C20H25N5 |
| Tofatinib Impurity 3 | 1206825-36-6 | C13H19N5 |
| Tofatinib Impurity 4 | 923036-30-0 | C27H31N5O2S |
| Tofatinib Impurity 6 | 3680-69-1 | C6H4ClN3 |
| Tofatinib Impurity 9 | 694495-63-1 | C8H10N2O2 |
| Tofatinib Impurity 10 | 1204176-45-3 | C8H16N2O2 |
| Tofatinib Impurity 11 | 1206875-41-3 | C15H22N2O2 |
| Tofatinib Impurity 12 | 2227199-31-5 | C20H29N5O3 |
| Tofatinib Impurity 13 | 1354469-76-3 | C7H16N2 |
| Tofatinib Impurity 16 | 1616761-00-2 | C16H19ClN6O |
| Tofatinib Impurity 18 | 1260614-73-0 | C13H19N5 |
| Tofatinib Impurity 19 | 2056104-91-5 | C27H31N5O2S |
| Tofatinib Impurity 20 | 1092578-44-3 | C27H31N5O2S |
| Tofatinib Impurity 21 | 1640971-60-3 | C14H20N6O |
| Tofatinib Impurity 22 | 1092578-45-4 | C20H25N5 |
| Tofatinib Impurity 23 | 1354621-59-2 | C14H22N2 |
| Tofatinib Impurity 24 | 2183519-70-0 | C15H23N5 |
| Tofatinib Impurity 25 | 2459302-85-1 | C21H27N7O3 |
| Tofatinib Impurity 26 | 1616761-01-3 | C17H23N5O3 |
| Tofatinib Impurity 30 | 1675248-18-6 | C18H25N5O3 |
| Tofatinib Impurity 31 | 1243290-37-0 | C15H21N5O2 |
| Tofatinib Impurity 32 | 1640971-51-2 | C16H20N6O2 |
| Tofatinib Impurity 33 | 1527525-58-1 | C15H18N6O |
| Tofatinib Impurity 34 (HCI) | 1821769-41-8 | C14H24Cl2N2 |
| Tofatinib Impurity 35 | 1638499-31-6 | C14H22N2 |
| Tofatinib Impurity 42 | 2716897-36-6 | C23H31N7O3 |
| Tofatinib Impurity 44 | 2504210-38-0 | C19H22N8 |
| Tofatinib Impurity 47 | 16372-08-0 | C6H6ClN3 |
| Tofatinib Impurity A | 1092578-46-5 | C16H20N6O |
| Tofatinib Impurity B | 1092578-48-7 | C16H20N6O |
| Tofatinib Impurity C | 1092578-47-6 | C16H20N6O |
| Tofatinib Impurity C (Citrate) | 2174011-55-1 | C22H28N6O8 |
| Tofatinib Impurity D | 1252883-90-1 | C20H25N5 |
| Tofatinib Impurity E | 1616760-97-4 | C13H18ClN5 |
| Tofatinib Impurity H | 1638499-33-8 | C14H22N2 |
| Tofatinib Impurity K | 2227197-38-6 | C14H21N5 |
| Tofatinib Impurity L | 477600-76-3 | C15H21N5O |
| Tofatinib Impurity N | 1640972-35-5 | C16H22N6O |
| Tofatinib Impurity Q | 1675248-19-7 | C16H22N6O2 |
| Tofatinib Impurity T | 1092578-43-2 | C16H20N6O |
| Tofatinib Impurity U | 2459302-78-2 | C34H45N7 |
| Tofatinib Impurity Y | 2459302-77-1 | C19H21N7O2 |
| Tolbutamide Imp. A (EP): (4-Methylphenyl)sulfonamide (Toluenesulfonamide; 4-Methylbenzene- sulfonamide) | 70-55-3 | C7H9NO2S |
| Tolcapone Related Compound A | 1391053-03-4 | C14H12O3 |
| Tolcapone Related Compound A (4’- methyl-3,4-dihydroxybenzophenone) | Not available | C14H12O3 |
| Tolcapone Related Compound B | 134612-80-9 | C15H13NO5 |
| Tolfenamic Acid EP Impurity B | 87-60-5 | C7H8ClN |
| Tolnaftate EP Impurity B | 127084-74-6 | C21H14O2S |
| Tolnaftate EP Impurity D | 696-44-6 | C8H11N |
| Tolnaftate for system suitability | 2398-96-1 | C19H17NOS |
| Tolnaftate Imp. A (EP): Naphthalen-2-ol ( -Naphthol) | 135-19-3 | C10H8O |
| Tolnaftate Imp. D (EP): N,3-Dimethylaniline (N-Methyl-m-toluidine) | 696-44-6 | C8H11N |
| Tolnaftate Impurity 1 | 10506-37-3 | C11H7ClOS |
| Tolnaftate Impurity 4 (2,2'-dinaphthyl ether) | 613-80-9 | C20H14O |
| Tolnaftate Impurity 5 | 128726-56-7 | C18H20N2S4 |
| Tolnaftate Impurity 6 | 10103-06-7 | C12H12O2 |
| Tolnaftate-d7 | 1329835-64-4 | C19H17NOS |
| Tolterodine <I>S</I>-Enantiomer | 873551-03-2 | C26H37NO7 |
| Tolterodine for system suitability | 124937-52-6 | C26H37NO7 |
| Tolterodine impurity 1 | 124936-82-9 | C22H31NO |
| Tolterodine impurity 2 | 851789-43-0 | C16H18O2 |
| Tolterodine impurity 3 | 200801-70-3 | C22H31NO2 |
| Tolterodine impurity E | 480432-14-2 | C19H25NO |
| Tolterodine impurity E | 124937-73-1 | C17H20O2 |
| Tolterodine S-Enantiomer | 873551-03-2 | C26H37NO7 |
| Tolterodine Tartrate EP Impurity A | 124937-73-1 | C17H20O2 |
| Tolterodine Tartrate EP Impurity D | 1391053-65-8 | C20H27NO |
| Tolterodine Tartrate EP Impurity E | 480432-14-2 | C19H25NO |
| Tolterodine Tartrate EP Impurity F | 124937-53-7 | C22H31NO |
| Toluene | 108-88-3 | C7H8 |
| Tolvaptan Impurity 3 | 1432725-23-9 | C26H26N2O3 |
| Tolvaptan Impurity 4 | 137973-76-3 | C26H23ClN2O3 |
| Tolvaptan impurity 4 | 176970-21-1 | C26H23ClN2O2 |
| Tolvaptan Impurity 6 | 1432725-24-0 | C18H19ClN2O2 |
| Tolvaptan Impurity 6 | 2486-75-1 | C8H9NO2 |
| Tolvaptan Impurity 7 | 118-90-1 | C8H8O2 |
| Tolvaptan Impurity 7 | 1580889-33-3 | C25H23ClN2O3 |
| Tolvaptan Impurity 8 | 317374-08-6 | C16H15NO3 |
| Tolvaptan Impurity 9 | 160129-45-3 | C10H10ClNO |
| Tolvaptan Impurity 10 | 137977-97-0 | C18H17ClN2O2 |
| Tolvaptan Impurity 10 | 933-88-0 | C8H7ClO |
| Tolvaptan Impurity 11 | 150683-27-5 | C25H23ClN2O3 |
| Tolvaptan Impurity 11 | 331947-69-4 | C16H14ClNO2 |
| Tolvaptan Impurity 13 | 1580889-36-6 | C42H36ClN3O5 |
| Tolvaptan Impurity 16 | 1580889-25-3 | C26H25ClN2O3 |
| Topipristal impurity 9 (Ethyl 2-cyanoisoniacinic acid) | 58481-14-4 | C9H8N2O2 |
| Topiramate EP Impurity A | 20880-92-6 | C12H20O6 |
| Topiramate EP Impurity B | 876403-98-4 | C17H30N2O9S |
| Topiramate EP Impurity C | 106881-41-8 | C9H17NO8S |
| Topiramate EP Impurity D | 950603-46-0 | C25H39NO15S |
| Topiramate EP Impurity E | 57-48-7 | C6H12O6 |
| Topiramate Impurity 6 | 851957-35-2 | C9H17NO8S |
| Topiramate Impurity 12 | 106881-42-9 | C6H13NO8S |
| Topiramate Impurity 14 | 912456-61-2 | C9H16O6 |
| Topiramate Impurity 16 | 10489-81-3 | C6H12O6 |
| Topiramate Impurity 17 | 58238-46-3 | C9H16O6 |
| Topiramate Impurity 18 | 38029-84-4 | C6H12O6 |
| Topiramate impurity A | 20880-92-6 | C12H20O6 |
| Topiramate impurity E CRS | 57-48-7 | C6H12O6 |
| Topiramate Related Compound A | 20880-92-6 | C12H20O6 |
| Topiroxostat | 577778-58-6 | C13H8N6 |
| Topiroxostat Impurity 1 | 2044702-36-3 | C13H9N5O2 |
| Topiroxostat Impurity 1 | 2044708-04-3 | C7H10N6O |
| Topiroxostat Impurity 2 | 4329-78-6 | C12H9N5 |
